LitAlert ~~

    • Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access.
    • Amendola LM, Shuster E, Leo MC., Dorschner MO, Rolf BA, Shirts BH, Gilmore MJ, Okuyama S, Zepp JM, Kauffman TL, Mittendorf KF, Bellcross C, Jenkins CL, Joseph G, Riddle L, Syngal S, Ukaegbu C, Goddard KAB, Wilfond BS, Jarvik GP; On behalf of theCHARM Study.
    • Genet Med. 2022 Mar 16. doi: 10.1016/j.gim.2022.02.006. Epub ahead of print.
    • The Features of BRCA1 and BRCA2 Germline Mutations in Hakka Ovarian Cancer Patients: BRCA1 C.536 A>T Maybe a Founder Mutation in This Population.
    • Luo Y, Wu H, Huang Q, Rao H, Yu Z, Zhong Z.
    • Int J Gen Med. 2022 Mar 10;15:2773-2786. doi: 10.2147/IJGM.S355755.